/term/enterprise-value-to-ebitda/NZSE:BLT BLIS Technologies (NZSE:BLT) EV-to-EBITDA
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » BLIS Technologies Ltd (NZSE:BLT) » Definitions » EV-to-EBITDA

BLIS Technologies (NZSE:BLT) EV-to-EBITDA : 12.83 (As of Jun. 20, 2024)


View and export this data going back to 2001. Start your Free Trial

What is BLIS Technologies EV-to-EBITDA?

EV-to-EBITDA is calculated as enterprise value divided by its EBITDA. As of today, BLIS Technologies's enterprise value is NZ$16.10 Mil. BLIS Technologies's EBITDA for the trailing twelve months (TTM) ended in Mar. 2024 was NZ$1.26 Mil. Therefore, BLIS Technologies's EV-to-EBITDA for today is 12.83.

The historical rank and industry rank for BLIS Technologies's EV-to-EBITDA or its related term are showing as below:

NZSE:BLT' s EV-to-EBITDA Range Over the Past 10 Years
Min: -1232.23   Med: -13.43   Max: 83.37
Current: 12.83

During the past 13 years, the highest EV-to-EBITDA of BLIS Technologies was 83.37. The lowest was -1232.23. And the median was -13.43.

NZSE:BLT's EV-to-EBITDA is ranked worse than
59.52% of 462 companies
in the Biotechnology industry
Industry Median: 8.44 vs NZSE:BLT: 12.83

EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

As of today (2024-06-20), BLIS Technologies's stock price is NZ$0.019. BLIS Technologies's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2024 was NZ$0.001. Therefore, BLIS Technologies's PE Ratio for today is 19.00.

The "classic" EV-to-EBITDA is much better in capturing debt and net cash than the PE Ratio.


BLIS Technologies EV-to-EBITDA Historical Data

The historical data trend for BLIS Technologies's EV-to-EBITDA can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

BLIS Technologies EV-to-EBITDA Chart

BLIS Technologies Annual Data
Trend Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24
EV-to-EBITDA
Get a 7-Day Free Trial Premium Member Only Premium Member Only 29.94 72.66 -21.93 -39.16 10.79

BLIS Technologies Semi-Annual Data
Sep14 Mar15 Sep15 Mar16 Sep16 Mar17 Sep17 Mar18 Sep18 Mar19 Sep19 Mar20 Sep20 Mar21 Sep21 Mar22 Sep22 Mar23 Sep23 Mar24
EV-to-EBITDA Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -21.93 - -39.16 - 10.79

Competitive Comparison of BLIS Technologies's EV-to-EBITDA

For the Biotechnology subindustry, BLIS Technologies's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


BLIS Technologies's EV-to-EBITDA Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, BLIS Technologies's EV-to-EBITDA distribution charts can be found below:

* The bar in red indicates where BLIS Technologies's EV-to-EBITDA falls into.



BLIS Technologies EV-to-EBITDA Calculation

BLIS Technologies's EV-to-EBITDA for today is calculated as:

EV-to-EBITDA=Enterprise Value (Today)/EBITDA (TTM)
=16.099/1.255
=12.83

BLIS Technologies's current Enterprise Value is NZ$16.10 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. BLIS Technologies's EBITDA for the trailing twelve months (TTM) ended in Mar. 2024 was NZ$1.26 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


BLIS Technologies  (NZSE:BLT) EV-to-EBITDA Explanation

EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

BLIS Technologies's PE Ratio for today is calculated as:

PE Ratio=Share Price (Today)/Earnings per Share (Diluted) (TTM)
=0.019/0.001
=19.00

BLIS Technologies's share price for today is NZ$0.019.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. BLIS Technologies's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2024 was NZ$0.001.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Study has found that the companies with the lowest EV-to-EBITDA outperforms companies measured as cheap by other ratios such as PE Ratio.

Please read Which price ratio outperforms the enterprise multiple?


BLIS Technologies EV-to-EBITDA Related Terms

Thank you for viewing the detailed overview of BLIS Technologies's EV-to-EBITDA provided by GuruFocus.com. Please click on the following links to see related term pages.


BLIS Technologies (NZSE:BLT) Business Description

Traded in Other Exchanges
N/A
Address
442 Moray Place, Ground Floor, Dunedin, OTA, NZL, 9016
BLIS Technologies Ltd is engaged in developing oral probiotics. The company markets two strains of probiotic bacteria BLIS K12, BLIS Q24, and BLIS M18 both of which occur naturally in the oral cavity. Its product portfolio consists of probiotic serum, Teeth and gums lozenge, fresh breath lozenge, and immune lozenge. Geographically, the company derives a majority of its revenue from EMEA (Europe, the Middle East, and Africa).

BLIS Technologies (NZSE:BLT) Headlines

From GuruFocus

Ariel Fund Quarterly Commentary From John Rogers

By Holly LaFon Holly LaFon 01-21-2016

John Rogers Exits Blount International in 1st Quarter

By David Goodloe David Goodloe 06-12-2016

Bill Nygren's Oakmark Comments on Blount International

By Holly LaFon Holly LaFon 07-10-2012

Jean-Marie Eveillard Sells More Blount International

By Holly LaFon Holly LaFon 10-09-2012

John Rogers' Recent Trades

By Tiziano Frateschi Tiziano Frateschi 04-06-2016

John Rogers Trims Stake in Blount International

By Kyle Ferguson Kyle Ferguson 04-18-2016